DE60209442D1 - Phaseolamin-Zusammensetzungen und Verfahren zur Anwendung derselben - Google Patents
Phaseolamin-Zusammensetzungen und Verfahren zur Anwendung derselbenInfo
- Publication number
- DE60209442D1 DE60209442D1 DE60209442T DE60209442T DE60209442D1 DE 60209442 D1 DE60209442 D1 DE 60209442D1 DE 60209442 T DE60209442 T DE 60209442T DE 60209442 T DE60209442 T DE 60209442T DE 60209442 D1 DE60209442 D1 DE 60209442D1
- Authority
- DE
- Germany
- Prior art keywords
- methods
- compositions
- phaseolamine
- same
- mineral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/02—Treatment of flour or dough by adding materials thereto before or during baking by adding inorganic substances
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/264—Vegetable proteins
- A21D2/266—Vegetable proteins from leguminous or other vegetable seeds; from press-cake or oil bearing seeds
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/267—Microbial proteins
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/368—Fermentation by-products, e.g. grapes, hops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0056—Spread compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/195—Proteins from microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/56—Protease inhibitors from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/962,917 US6797287B2 (en) | 2001-09-25 | 2001-09-25 | Phaseolamin compositions and methods for using the same |
US962917 | 2001-09-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60209442D1 true DE60209442D1 (de) | 2006-04-27 |
DE60209442T2 DE60209442T2 (de) | 2006-10-12 |
Family
ID=25506500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60209442T Expired - Lifetime DE60209442T2 (de) | 2001-09-25 | 2002-09-25 | Phaseolamin-Zusammensetzungen und Verfahren zur Anwendung derselben |
Country Status (7)
Country | Link |
---|---|
US (3) | US6797287B2 (de) |
EP (2) | EP1618801A1 (de) |
AT (1) | ATE318609T1 (de) |
CA (1) | CA2390215C (de) |
DE (1) | DE60209442T2 (de) |
ES (1) | ES2259360T3 (de) |
HK (1) | HK1054299B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005535643A (ja) * | 2002-06-28 | 2005-11-24 | ファーマケム・ラボラトリーズ・インコーポレイテッド | 精製されたアミラーゼ阻害剤およびその新規取得方法 |
US7108869B2 (en) * | 2002-11-07 | 2006-09-19 | Access Business Group International Llc | Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors |
ITMI20030391A1 (it) * | 2003-03-04 | 2004-09-05 | S I I T S R L Servizio Internaz Ionale Imballa | Formulazioni anticarie a base di faseolamina. |
US20050003027A1 (en) * | 2003-05-09 | 2005-01-06 | Diaz Jose A. | Chemical composition and method to bind fat, enhance metabolization, and aid digestion |
PL209905B1 (pl) * | 2004-01-15 | 2011-11-30 | Bringwell Internat Ab | Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego |
ITMI20040313A1 (it) * | 2004-02-24 | 2004-05-24 | S I I T S R L Servizio Interna | Formulazioni gastroprotette di inbitori di enzimi ad attivita' alfa-amilasica |
ITMI20040619A1 (it) * | 2004-03-30 | 2004-06-30 | Consiglio Nazionale Ricerche | Estratto purificato di inibitore dell'alfa-amilasi da fagioli essenzialmente privi di fitoemoagglutinina procedimento di estrazione e composizioni che lo contengono |
US20050238638A1 (en) * | 2004-04-21 | 2005-10-27 | Jonathan Gutwein | Dietary Supplement that Serves as a Carbohydrate Blocker and Hangover Remedy |
US7476406B1 (en) * | 2004-05-17 | 2009-01-13 | Nse Products, Inc. | Multifaceted weight control system |
US7588759B2 (en) * | 2004-12-17 | 2009-09-15 | Avoca, Inc. | Compositions comprising sclareol or derivatives thereof and uses thereof |
US20060257332A1 (en) * | 2005-05-13 | 2006-11-16 | Pierro Francesco D | Anticaries compositions containing phaseolamin |
FR2892894B1 (fr) * | 2005-11-08 | 2008-01-11 | Juva Soc Par Actions Simplifie | Complement alimentaire comprenant de la phaseolamine. |
ITMI20052450A1 (it) * | 2005-12-22 | 2007-06-23 | Indena Spa | Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono |
ITMI20052451A1 (it) * | 2005-12-22 | 2007-06-23 | Indena Spa | Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono |
ES2581734T3 (es) * | 2006-11-20 | 2016-09-07 | S.I.I.T. S.R.L.-Servizio Internazionale Imballaggi Termosaldanti | Composiciones que contienen extracto de Phaseolus vulgaris y extracto de Alpinia officinarum para la prevención y el tratamiento de la obesidad y la diabetes tipo II |
EP1967200A1 (de) * | 2007-03-07 | 2008-09-10 | Indena S.P.A. | Formulierungen aus Alpha-Amylase-Hemmern von P. vulgaris mit Alpha-Glucosidase-Hemmern von S. oblonga oder S. reticulata zur Behandlung von Diabetes und Adipositas |
US7940861B2 (en) * | 2007-12-07 | 2011-05-10 | Advantech Advanced Microwave Technologies, Inc. | QAM phase error detector |
FR2934468A1 (fr) * | 2008-07-31 | 2010-02-05 | Christian Fenioux | Composition stabilisee a base d'extrait de haricot diminuant notamment l'index glycemique des produits alimentaires a base d'amidon et permettant un meilleur controle du poids. |
US20100040732A1 (en) * | 2008-08-18 | 2010-02-18 | Vdf Futureceuticals, Inc. | Compositions and Methods for Fermented Nutraceuticals |
AU2010206549B2 (en) * | 2009-01-26 | 2016-08-25 | Dcb-Usa, Llc | Use of pterosin compounds for treating diabetes and obesity |
GB2507254A (en) * | 2012-09-13 | 2014-04-30 | Ajit Ramanial Patel | Composition for reducing the consumption of food and the absorption of carbohydrate constituents thereof |
US20200367547A1 (en) * | 2017-03-21 | 2020-11-26 | Pharmachem Laboratories, Llc | Controlled release of phaseolamin compositions |
CN108576735B (zh) * | 2018-05-09 | 2022-03-15 | 北京市农林科学院 | 一种具有抑制淀粉分解作用的果冻及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE151869C (de) | ||||
DE2628757A1 (de) | 1976-06-26 | 1977-12-29 | Guenter Dr Woeber | Amylase inhibitor |
DD151869A1 (de) * | 1980-07-09 | 1981-11-11 | Joachim Doerfer | Verfahren zur inhibierung der alpha-amylaseaktivitaet bei der backwarenherstellung aus enzymreichen mehlen |
JPH0393800A (ja) * | 1989-09-05 | 1991-04-18 | Sumitomo Chem Co Ltd | インゲンマメ種子から抽出したアズキゾウムシ等の幼虫の生育阻害物質 |
US5612039A (en) | 1994-03-14 | 1997-03-18 | Nini E. Policappelli | Dietary supplement |
CA2360065A1 (en) | 1999-01-22 | 2000-07-27 | Hunza Di Maria Carmela Marazzita S.A.S. | Lipoprotein complexes and compositions containing them |
GB9921229D0 (en) | 1999-09-08 | 1999-11-10 | Med Eq As | Compositions |
-
2001
- 2001-09-25 US US09/962,917 patent/US6797287B2/en not_active Expired - Lifetime
-
2002
- 2002-07-02 CA CA2390215A patent/CA2390215C/en not_active Expired - Lifetime
- 2002-09-03 US US10/233,643 patent/US6900174B2/en not_active Expired - Lifetime
- 2002-09-25 EP EP05077278A patent/EP1618801A1/de not_active Withdrawn
- 2002-09-25 EP EP02078977A patent/EP1295535B1/de not_active Expired - Lifetime
- 2002-09-25 DE DE60209442T patent/DE60209442T2/de not_active Expired - Lifetime
- 2002-09-25 AT AT02078977T patent/ATE318609T1/de not_active IP Right Cessation
- 2002-09-25 ES ES02078977T patent/ES2259360T3/es not_active Expired - Lifetime
-
2003
- 2003-09-16 HK HK03106641.7A patent/HK1054299B/zh not_active IP Right Cessation
-
2004
- 2004-11-24 US US10/997,315 patent/US7049288B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7049288B2 (en) | 2006-05-23 |
CA2390215A1 (en) | 2003-03-25 |
ATE318609T1 (de) | 2006-03-15 |
US20030059457A1 (en) | 2003-03-27 |
DE60209442T2 (de) | 2006-10-12 |
EP1295535B1 (de) | 2006-03-01 |
ES2259360T3 (es) | 2006-10-01 |
EP1295535A3 (de) | 2003-07-09 |
CA2390215C (en) | 2010-12-07 |
US6797287B2 (en) | 2004-09-28 |
US20030059403A1 (en) | 2003-03-27 |
EP1295535A2 (de) | 2003-03-26 |
EP1618801A1 (de) | 2006-01-25 |
US20050152952A1 (en) | 2005-07-14 |
HK1054299B (zh) | 2006-05-26 |
US6900174B2 (en) | 2005-05-31 |
HK1054299A1 (en) | 2003-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60209442D1 (de) | Phaseolamin-Zusammensetzungen und Verfahren zur Anwendung derselben | |
MX2007006104A (es) | Metodos para purificar trans-(-)-?9-tetrahidrocanabinol y trans-(+)-?9-tetrahidrocanabinol. | |
FI942573A (fi) | Koostumus, joka käsittää hyytymistekijä VIII -formuloinnin, sen valmistusmenetelmä ja pinta-aktiivisen aineen käyttö stabilointiaineena | |
UA94913C2 (ru) | Применение эритропоэтина для лечения сахарного диабета | |
BRPI0515596A (pt) | composição farmacêutica usada para o tratamento e/ou prevenção de hcv, e, métodos de inibir rna polimerase ns5b de hepatite c de tratar ou prevenir infecção por hepatite c em um mamìfero | |
DE60224928D1 (de) | Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat | |
HK1084404A1 (en) | Muteins of tear lipocalin | |
DE60330757D1 (de) | Verwendung von pyridylamiden als angiogenesehemmer | |
BR0206831A (pt) | Composto, cristal, agente farmacêutico, agentes para profilaxia ou tratamento de diabetes, de complicações diabéticas, de tolerância prejudicada à glucose e de obesidade, inibidor de peptidase, uso de um composto, e, método de produção de um composto | |
WO2005037199A3 (en) | Pyrazole derivatives as cannabinoid receptor modulators | |
BR0208142A (pt) | Combinações compreendendo um agente antidiarréico e epotilona ou derivado de epotilona | |
BR0212968A (pt) | Composição farmacêutica, composto, e, método para tratar ou prevenir condições mediadas pelo ccr2, mcp-1 ou pela interação destes | |
ATE479655T1 (de) | Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative | |
BR0214884A (pt) | Derivados de 7-amino-benzotiazol como ligantes do receptor de adenosina | |
AU2003218110A1 (en) | C3-cyano epothilone derivatives | |
BR9916680A (pt) | Derivados da 3,3-biarilpiperidina e2,2-biarilmorfolina | |
NZ516290A (en) | Substituted phenoxyacetic acids | |
DK1096865T3 (da) | Antimikrobiel sammensætning | |
DE60230961D1 (de) | Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung | |
BR0213317A (pt) | Uso de um composto, método de tratar um distúrbio relacionado com gastrina, composição farmacêutica, kit, usos de uma composição, e de um inibidor de bomba de próton, métodos de preparar uma composição farmacêutica e um composto, e, composto | |
BR0311223A (pt) | Método para o uso de derivados de piranindol para tratar infecção pelo vìrus da hepatite c | |
BR9916537A (pt) | Composição de fragrância, produto, uso de camonal, ciprisato, elintaal e/ou dispirona, e, processo para aumentar as propriedades de redução do malodor de uma composição de fragrância | |
DE69402441D1 (de) | Neue 17,20-Epoxyd Derivate von Pregnan, ihre Verwendung zur Herstellung von Cortison-Derivaten und Zwischenprodukte dafür | |
ATE334977T1 (de) | Discodermolid-analoga und ihre pharmazeutische verwendung | |
AU7287891A (en) | Novel ascorbic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |